Literature DB >> 6094425

Penetration of cefotaxime into heart valves, subcutaneous and muscle tissue of patients undergoing open-heart surgery.

H M Just, M Bassler, U Frank, G Spillner, V Schlosser, F Daschner.   

Abstract

Twenty-nine adult patients undergoing open-heart surgery were given 2 g cefotaxime as 5 min intravenous bolus injection preoperatively. Within 6 h cefotaxime serum concentrations declined from 81.0 to 6.3 mg/l. Subcutaneous tissue and muscle concentrations varied between 0.3 and 8.7 micrograms/g, heart valve concentrations varied between 2.2 and 13.0 micrograms/g. Cefotaxime concentrations in heart valves are high enough to inhibit most Gram-negative organisms causing postoperative wound infections and endocarditis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6094425     DOI: 10.1093/jac/14.4.431

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  Cefotaxime and flucloxacillin as antibiotic prophylaxis in cardiac transplantation.

Authors:  A Khaghani; M Martin; M Fitzgerald; M Skacel; D Aravot; M H Yacoub
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 2.  Cefotaxime. An update of its pharmacology and therapeutic use.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

Review 3.  Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections.

Authors:  R N Brogden; C M Spencer
Journal:  Drugs       Date:  1997-03       Impact factor: 9.546

4.  Aztreonam concentrations in human tissues obtained during thoracic and gynecologic surgery.

Authors:  T R Beam; R P Galask; L T Friedhoff; T B Platt; M A Leitz
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.